No pharmacokinetic interaction appears to occur between
theophylline and
doxapram in neonates. However, the manufacturers of
doxapram say that
clinical data suggests there may be an interaction (not confined to neonates), which is manifested by agitation and increased skeletal muscle activity.
Although this reaction seems rare, it would be prudent to monitor concurrent use for any adverse outcome.